e-learning
resources
Monograph
2012
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Omics and single molecule detection: the future of TB diagnostics
Graham H. Bothamley, Morten Ruhwald, Delia Goletti
Source:
Eur Respir Monogr 2012; 58: 144-153
Journal Issue:
Tuberculosis
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Graham H. Bothamley, Morten Ruhwald, Delia Goletti. Omics and single molecule detection: the future of TB diagnostics. Eur Respir Monogr 2012; 58: 144-153
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015
Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients
Source: Eur Respir J 2006; 28: 31-34
Year: 2006
Comparative mycobacterial genomics as a tool for drug target and antigen discovery
Source: Eur Respir J 2002; 20: 78S-86S
Year: 2002
Time interval to conversion of interferon-? release assay after exposure to tuberculosis
Source: Eur Respir J 2011; 37: 1447-1452
Year: 2011
TB as an occupational disease
Source: Eur Respir Mon 2012; 58: 219-229
Year: 2012
Are interferon- gamma release assays useful for diagnosing active tuberculosis in a high-burden setting?
Source: Eur Respir J 2011; 38: 649-656
Year: 2011
Direct costs of three models for the screening of latent tuberculosis infection
Source: Eur Respir J 2006; 28: 45-50
Year: 2006
Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms
Source: Eur Respir J 2012; 39: 163-171
Year: 2012
Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms
Source: Eur Respir J 2011; 39: 163-171
Year: 2012
Immunotherapy (as an adjuvant therapeutic tool) of tuberculosis - does it have a future?
Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem
Year: 2005
Application of the novel technique next gene sequencing for the determination of mycobacterium tuberculosis resistance in clinical samples
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013
Additional analysis of antigen-specific Interleukin-2 release does not improve the performance of IGRAs for the differentiation of different states of
mycobacterium tuberculosis
infection
Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection
Year: 2014
Clinical evaluation of diagnostic potential of several biomarkers for immunodiagnosis of tuberculosis infection including IGRAs
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015
Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis
Source: Eur Respir J 2011; 37: 100-111
Year: 2011
CD27 expression as a new tool to distinguish active tuberculosis from latent infection
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015
Improved performances of the Quantiferon-TB in tube assay with novel mycobacterium tuberculosis specific antigenic peptides
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
Enhanced diagnosis of tuberculosis using a dual gene target detection approach
Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR
Year: 2016
Rapid detection of mycobacterial growth in in vitro cultures by VOC analysis
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
Clinical evaluation of several biomarkers including IFN-γ for the diagnosis of tuberculosis infection
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016
Outcomes of early interferon-gamma release assay (IGRA) testing in recent contacts of smear positive pulmonary tuberculosis (TB)
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept